<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "https://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article article-type="research-article" dtd-version="1.1" specific-use="sps-1.9" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Indian Journal of Mental Health and Neurosciences</journal-id>
<journal-id journal-id-type="publisher-id">IJMHNS</journal-id>
<journal-title-group>
<journal-title>Indian Journal of Mental Health and Neurosciences</journal-title>
<abbrev-journal-title abbrev-type="publisher">IJMHNS</abbrev-journal-title>
</journal-title-group>
<issn pub-type="epub">2581-9445</issn>
<publisher>
<publisher-name>Indian Psychiatric Society - Tamil Nadu</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.32746/ijmhns.2019.v2.i1.13</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>ORIGINAL ARTICLE</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Epigenetics In Psychiatry</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Mahatme</surname>
<given-names>Nupur</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shettar</surname>
<given-names>Manoj</given-names>
</name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kakunje</surname>
<given-names>Anil</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kini</surname>
<given-names>Ganesh</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
</contrib>
</contrib-group>
<aff id="aff1">
<label>1</label>
<institution content-type="original">Yenepoya Medical College Hospital, Mangalore</institution>
<institution content-type="orgname">Yenepoya Medical College Hospital</institution>
<addr-line>
<named-content content-type="city">Mangalore</named-content>
</addr-line>
</aff>
<aff id="aff2">
<label>2</label>
<institution content-type="original">SDM Medical College Dharwad</institution>
<institution content-type="orgname">SDM Medical College</institution>
<addr-line>
<named-content content-type="city">Dharwad</named-content>
</addr-line>
</aff>
<author-notes>
<corresp id="c1"><bold>Corresponding author:</bold> Nupur Mahatme, Department of Psychiatry, Yenepoya Medical College Hospital, Mangalore Email: <email>nupur.mahatme@gmail.com</email></corresp>
</author-notes>
<pub-date date-type="pub" publication-format="electronic">
<day>02</day>
<month>09</month>
<year>2025</year>
</pub-date>
<pub-date date-type="collection" publication-format="electronic">
<year>2024</year>
</pub-date>
<volume>2</volume>
<issue>1</issue>
<fpage>3</fpage>
<lpage>11</lpage>
<history>
<date date-type="received">
<day>01</day>
<month>07</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>01</day>
<month>07</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2024 Indian Psychiatric Society &#x2014; Tamil Nadu Branch</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Indian Psychiatric Society &#x2014; Tamil Nadu Branch</copyright-holder>
<license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/" xml:lang="en">
<license-p>This is an open access article distributed under the terms of the Creative Commons license.</license-p>
</license>
</permissions>
<abstract>
<title>ABSTRACT</title>
<p>Epigenetics is defined as the changes in gene expression that lead to predictable, stable and possibly heritable alterations in cell function that are not due to changes in DNA sequence. It is of major relevance in psychiatry since environmental factors like stress or substance abuse, significant contribute in causing psychiatric pathologies like depression, anxiety, depression, etc.</p>
<p>Epigenetics research in psychiatry would give an opportunity to extend the outlook and approach towards psychiatric pathologies. Hence timely interventions would be sought for. This would also allow gaining access to &#x2018;brain tissue&#x2019; from live patients with mental illness and predicting occurrence of or vulnerability to psychiatric illnesses by evaluation of biomarkers, thus preventing, reversing or atleast curbing the progress at an initial stage.</p>
<p>There are evidences of work done in the field of epigenetics both in pre-clinical as well as clinical settings. It is remarkable to see how the DNA methylation at various sites can result in alteration of the mental health of an individual and also how this can affect as early as during the first week of life. This is an exciting frontier in psychiatry, providing long sought biomarkers for predicting complex and devastating human behaviours as well as mental illnesses.</p>
</abstract>
<kwd-group xml:lang="en">
<title>Keywords</title>
<kwd>Epigenetics</kwd>
<kwd>psychiatry</kwd>
<kwd>gene-environmental interaction</kwd>
<kwd>vulnerability</kwd>
<kwd>psychiatric pathologies.</kwd>
</kwd-group>
<counts>
<ref-count count="28"/>
</counts>
</article-meta>
</front>
<body>
<sec sec-type="intro">
<title>INTRODUCTION</title>
<p>The term &#x201C;epigenetics&#x201D; was coined by fusing the two terms &#x201C;genetics&#x201D; and &#x201C;epigenesis&#x201D; by Conrad Waddington in 1942. This term was used to describe the developmental program in a multi-cellular organism wherein the zygote gives rise to different cell types. Waddington defined it as &#x201C;the cooperation between genetic traits and environmental conditions that together established a stable cellular phenotype.&#x201D; Others also defined it as a stably heritable phenotype resulting from changes in a chromosome without alterations in the DNA sequence.<xref ref-type="bibr" rid="B1"><sup>1</sup></xref></p>
<p>The current definition used is &#x201C;Changes in gene expression that lead to predictable, stable and possibly heritable alterations in cell function that are not due to changes in DNA sequence.&#x201D; In psychiatry, this definition is particularly relevant since environmental factors, such as stress or substance abuse, alter the expression of genes in post-mitotic neurons that are not heritable, but significantly contribute in causing psychiatric pathologies such as depression, anxiety and addiction.<xref ref-type="bibr" rid="B1"><sup>1</sup></xref></p>
<p>Different cell types can be generated by using the same genetic blueprint by mechanisms that are involved in epigenetics. The genetic code as well as the DNA sequence remains unchanged, however two different epigenetic programs read it differently, depending on what letters within the underlying code are more visible.<xref ref-type="bibr" rid="B1"><sup>1</sup></xref></p>
</sec>
<sec>
<title>Epigenetics in psychiatry</title>
<p>Epigenetics research is one of the most exciting and rapidly growing frontiers in psychiatric research. This is due to its potential to advance the field in six specific areas:<xref ref-type="bibr" rid="B1"><sup>1</sup></xref></p>
<list list-type="order">
<list-item><p>How environmental factors shape vulnerability to psychiatric conditions is explained by molecular mechanisms. For example, in cases of substance use, post-traumatic stress disorder (PTSD), contribution of environmental factors is quite obvious. In other examples like schizophrenia and bipolar disorder, a strong environmental influence can be there since concordance between monozygotic twins is slightly less than 50&#x0025;. It is also important to recognize that environmental manipulations can induce epigenetic changes that can alleviate psychiatric symptoms. In fact, many of the known interventions in psychiatry such as antidepressant medications, ECT, diet, exercise have shown to cause epigenetic changes that modify vulnerability to stress, anhedonia and drug seeking behaviours.</p></list-item>
<list-item><p>It can also explain how abnormal brain development can contribute to the vulnerability to many of the psychiatric conditions. We will further see how epigenetics plays a crucial role in modifying brain development and vulnerability to various psychopathologies in children exposed to abuse or neglect; thus, targeting for timely interventions.</p></list-item>
<list-item><p>Somatic cells can be harvested by researchers through this technique (eg skin cells) from individuals diagnosed with specific psychiatric illnesses (eg schizophrenia) and further their epigenetic code can be reprogrammed in a way that would transform them into neurons or glial cells, which can then be grown and studied in a culture. This allows gaining access to &#x2018;brain tissue&#x2019; from live patients with mental illness.</p></list-item>
<list-item><p>Heritability is calculated as the relative rates of concordance between monozygotic and dizygotic twins, and monozygotic twins share many more epigenetic similarities comparatively. Also the ability of some epigenetic markers to be inherited may explain how exposure to a specific stressor in the parental generation may modify the risk for psychopathology in the offspring.</p></list-item>
<list-item><p>Such gene-by-environment interactions have been demonstrated between alleles of the serotonin transporter and the ability of childhood maltreatment to modify risk of adult depression, elucidating the mechanism by which gene and environmental factors interact to modify vulnerability to mental illness, thus introducing more specific biomarkers and early interventions.</p></list-item>
<list-item><p>Provides reliable biomarkers are provided to diagnose psychiatric vulnerabilitiessuch as DNA methylation. Epigenetic changes can be a potentially valuable biomarker for diagnosing and assessing treatment response. Biomarkers are desperately needed in psychiatry where no objective disease markers are currently available to diagnose or assess treatment response.<xref ref-type="bibr" rid="B1"><sup>1</sup></xref></p></list-item>
</list>
</sec>
<sec>
<title>Epigenetic Modifications</title>
<p>The chemical structure of DNA as well as the amino acids of histones can undergo modifications such as methylation, phosphorylation, acetylation, etc. These processes are collectively called as epigenetic modifications, which are reversible and are carried out by large multi-subunit protein complexes that coordinate their activities that can either condense or open up the chromatin in response to the environmental cues.<xref ref-type="bibr" rid="B1"><sup>1</sup></xref></p>
</sec>
<sec>
<title>Molecular mechanisms of epigenetics</title>
<p>It includes DNA methylation, histone modification and RNA-associated silencing.<xref ref-type="bibr" rid="B1"><sup>1</sup></xref></p>
<p>DNA methylation depending on the position of the methylation change relative to the position of the transcription start site, inhibits gene transcription.DNA gets methylated at sites where there is cytosine by the enzymatic addition of a methyl group, using S adenosyl methionine (SAM) as the methyl group source, to the carbon-5 position of cytosine.<xref ref-type="bibr" rid="B2"><sup>2</sup></xref>Epigenetic alterations occur through DNA methylation of cytosine&#x2013;guanine base (CpG) dinucleotides using DNA methyltransferases (DNMT1, 3a, 3b).<xref ref-type="bibr" rid="B3"><sup>3</sup></xref></p>
<p>DNA methylation has functions like silencing of transposable elements, defense against viral sequences and transcriptional repression of certain genes.<xref ref-type="bibr" rid="B4"><sup>4</sup></xref></p>
<p>Studies on mice have shown that epigenetic modification through cytosine methylation and chromatin remodeling may get inherited to the next generations.<xref ref-type="bibr" rid="B5"><sup>5</sup></xref></p>
<p>The most abundant proteins in chromatin are histones. Histones can be modified through acetylation, methylation, and phosphorylation of the histone tail domains. Histone modifications results in dynamic transitions between gene activation and silencing.<xref ref-type="bibr" rid="B6"><sup>6</sup></xref></p>
<p>Enzymes involved in histone modification are histone acetyl transferases (HATs) and histonedeacetylases (HDACs). These modifications show effect on gene expression by altering the structural configuration of the genome.<xref ref-type="bibr" rid="B3"><sup>3</sup></xref></p>
<p>Small RNAs can silence genes at transcriptional and post-transcriptional levels. Small RNAs have 21 to 28 nucleotides. Small RNAs include micro RNAs (miRNAs) and small interfering RNA (siRNAs). RNA-mediated gene silencing is required for maintaining chromosomal structure, genome defense and gene regulation.<xref ref-type="bibr" rid="B7"><sup>7</sup></xref></p>
</sec>
<sec>
<title>Environmental factors</title>
<p>The environmental factors have an impact on epigenetic mechanisms in gene expression by many ways.Dietary levels of methionine, during prenatal and early postnatal life, influences susceptibility to chronic adult diseases because dietary methionine influences DNA methylation.<xref ref-type="bibr" rid="B8"><sup>8</sup></xref></p>
<p>Environmental factors can influence the epigenome. Pup licking and grooming (LG) and arched-back nursing (ABN) by rat mothers alters the offspring epigenome at a glucocorticoid receptor (GR) gene promoter in the hippocampus. Offspring of mothers that showed high levels of LG and ABN had differences in DNA methylation, as compared to offspring of 'low-LG-ABN' mothers.<xref ref-type="bibr" rid="B9"><sup>9</sup></xref></p>
</sec>
<sec>
<title>Psychosocial factors</title>
<p>Psychosocial factors like maternal behavior and stress reactivity in the offspring, transmission of such individual differences in maternal behavior from one generation of females to the next, environmental manipulation occurring during early development which alters maternal behavior can then affect the pattern of transmission in subsequent generations.<xref ref-type="bibr" rid="B10"><sup>10</sup></xref></p>
</sec>
<sec>
<title>Epigenetic inheritance</title>
<p>It is by three methods: Mitotic inheritance, meiotic inheritance and true transgenerational inheritance. <xref ref-type="bibr" rid="B11"><sup>11</sup></xref></p>
<p>Inheritance of the epigenome is a powerful tool by which adaption of one generation of organisms to a changed environment can be carried to many subsequent generations. This can result in either adaptive or negative effects in later generations. The classical twin study first proposed by Galton shows that there is a higher concordance rate between MZ twins compared with dizygotic (DZ) twins provides evidence for genes influencing phenotypes. MZ twins discordant for a trait are given as example for environmental factors influence in complex disease aetiology.<xref ref-type="bibr" rid="B12"><sup>12</sup></xref></p>
</sec>
<sec>
<title>Pre-clinical work in epigenetics</title>
<p>Epigenetic transmission of Stress reactivity and maternal behaviour -</p>
<p>The importance of early life experiences for the development of the organism has long been appreciated from both psychodynamic and biologic perspectives. Cases of early life abuse and neglect often fit into a trans-generational pattern in which childhood maltreatment is associated with maladaptive parenting styles later in life. Exposure to early life stress is linked with enhanced endocrine and autonomic responses to stress that persist into adulthood. This increased stress reactivity is closely related to increased risk for developing several psychopathologies including affective disorders, PTSD and substance use.<xref ref-type="bibr" rid="B1"><sup>1</sup></xref></p>
<p>Biological mechanisms were investigated by studying the parental styles in rats. It was observed that parental neglect increases stress reactivity in a manner that persists even into adulthood and further can also be transmitted across generations. Some of the mothers licked and groomed their pups almost three times more frequently compared to others during the first postpartum week, they have found to have profound behavioral phenotypes. For example off springs raised by high lick and groom (LG) mothers performed better in several memory tests, and were less fearful and showed decreased corticosteroid secretion in response to stress as compared to neglected offspring raised by low LG mothers. These behavioural changes are due to the frequency of LG during the first week of life and not due to genetic differences between them. Cross fostering studies have shown that offspring born to low LG mothers but raised by high LG mothers were behaviorally indistinguishable from pups born and raised by high LG mothers.<sup><xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B2">2</xref></sup></p>
<p>Rat pups were provided with different amount of paintbrush strokes which could mimic maternal behavior during the first week of life induced similar behavioural changes which persisted even in adulthood, indicating that exposure to different levels of tactile stimulation during the first week of life in some way programs adult behavior.</p>
<p>The frequency of LG during the first week of life causes stable changes in DNA methylation in promoter elements that regulate the expression of genes. For example, the promoter of glucocorticoid receptor (GR) is heavily methylated at birth, thus leading to low GR levels in the hippocampus of newborn pups. Demethylation of this GR promoter allows transcription activator NGF inducible protein A.<xref ref-type="bibr" rid="B1"><sup>1</sup></xref></p>
<p>Cortisol is produced in response to stress. The more stressed we are the more cortisol we produce. The average level of cortisol production tends to be raised in adults who had traumatic childhoods, even if they are healthy at the time of measurement. This shows that higher background stress levels are found in adults who were abused or neglected as their contemporaries.<xref ref-type="bibr" rid="B2"><sup>2</sup></xref></p>
<p>The development of mental illness is little like the development of cancer that a lot has to go wrong at the molecular level before a person becomes clinically ill. This increases their vulnerability to the disease. How does this over-expression of cortisol happen? There is a whole signaling cascade involved in here. During an abusive childhood, this signaling cascade is very active. In many abuse survivors, this system keeps signaling as if the person is still trapped in the abusive situation. It&#x2019;s as if the thermostat on a central heating system has malfunctioned, and the boilers and radiators continue to pump out heat in April, based on the weather from previous November.<xref ref-type="bibr" rid="B2"><sup>2</sup></xref></p>
<p>The process starts in a region of the brain called the hippocampus, where in because of changes in its activities in response to stress, the hypothalamus produces and releases two hormones, called corticotrophin releasing hormone and arginine vasopressin. These hormones stimulate the pituitary gland, which responds by releasing adrenocorticotropin hormone which gets into the bloodstream and when the cells of the adrenal gland take up this hormone, they release cortisol.<sup><xref ref-type="bibr" rid="B2">2</xref>&#x2013;<xref ref-type="bibr" rid="B4">4</xref></sup>Most important to epigenetic stress is that glucocorticoids are a prominent regulator of Hypothalamo-Pituitary-Adrenal (HPA) axis activation via negative feedback.<xref ref-type="bibr" rid="B5"><sup>5</sup></xref></p>
<p>Also it has been observed that increased LG behavior results in decreased DNA methylation at estrogen receptor &#x2013;&#x03B1; ( ER&#x03B1;) in medial pre-optic area (MPOA) in hypothalamus, which in turn recruits transcription factor Stat5, thus increasing ER&#x03B1; in medial pre-optic area in increased female LG offspring, subsequently improving maternal behaviour. These modifications can however be reversed by IV infusion of Histone deacetylase (HDAC) inhibitor which reduces the DNA methylation at GR promoter, thus increasing GR levels in hippocampus and decreasing stress reactivity in adult low LG offsprings. Similarly IV infusion of Methionine, increases DNA methylation at GR promoter, decreasing GR levels in hippocampus and in turn increasing stress reactivity in adult high LG offsprings.<xref ref-type="bibr" rid="B1"><sup>1</sup></xref></p>
<sec>
<title>Epigenetic Inheritance of Olfactory Fear Memory -</title>
<p>A critical survival function in both animals and humans is the ability to recognise, remember and avoid dangerous environmental signals. While humans rely strongly on visual cues, rodents scout their environment with their highly sensitive sense of smell.<xref ref-type="bibr" rid="B1"><sup>1</sup></xref></p>
<p>In mice, the repeated pairing of a specific odour referred as the &#x201C;offending odour&#x201D;, with a noxious stimulus such as foot shock, results in a fear memory that is manifested as an exaggerated startle when the rodent encounters the offending odour alone without the shock. Olfactory mediated memory is therefore considered as an adaptive form of sensitisation to environmental threats that help the mouse to predict and avoid danger.To test the inheritance of sensitivity to danger associated olfactory stimuli, mice were fear conditioned to a specific conditioned odor. This procedure was done in mice in which the neurons expressing the olfactory receptor coding for that specific offending odor were labeled with a LacZ reporter. The advantage of this allows the researcher to assess whether the sensitivity to the offending odor is accompanied by an increase in the expression of its receptor in the olfactory epithelium.<xref ref-type="bibr" rid="B1"><sup>1</sup></xref></p>
<p>Neuroanatomical examination of F1 and F2 mice showed that expression of the olfactory receptor responsive to the conditioned odor was selectively upregulated in the olfactory epithelium. To detect if this transgenerational transmission was due to epigenetic modifications, parental sperm was collected and IVF was done. DNA isolated from sperm of F0 and F1 showed hypomethylation in the vicinity of olfactory receptor responsible for that specific odor and not around others.<xref ref-type="bibr" rid="B1"><sup>1</sup></xref></p>
</sec>
<sec>
<title>Epigenetic Mechanisms of Depressive Behaviour and Anti-depressant Action -</title>
<p>Rodent models of depression and PTSD typically employ some form of chronic, unpredictable or severe stress that leads to despair, avoidance or anhedonic-like behaviours. These behavioural consequences could be reversed with chronic treatment with antidepressants, thus providing reasonable models of human depression and PTSD.<xref ref-type="bibr" rid="B1"><sup>1</sup></xref></p>
<p>One paradigm involves chronic defeat in which a mouse is briefly exposed to an aggressive intruder over the course of 10 days and the defeated mice shows decrease in sucrose consumption, suggesting an anhedonic-like state, increased helplessness in the forced swim and tail suspension tests. Behavioral consequences of social defeat and the rescue of depressive phenotype by antidepressant medications are due to epigenetic changes in the expression of the genes implicated in neuroplasticity. One of the best eg of epigenetic regulation of neuroplasticity genes is the opposing effects of stress and antidepressants on the expression of brain derived neurotropic factor (BDNF) in limbic brain areas. Antidepressants reverse the effects produced in defeated mice due toraised H3K27 methylation at BDNF promoter. Repressive chromatin state inhibits BDNF expression and thus downregulates expression of BDNF in hippocampus.<xref ref-type="bibr" rid="B1"><sup>1</sup></xref></p>
<p>In a study done by Natalia Onishchenko et al; it was seen that perinatal exposure of mice to Methyl Mercury can lead to long&#x2010;lasting depression&#x2010;like behavioural changes which was associated with repressive epigenetic changes in the regulation of the BDNF gene expression. When same mice during adulthood were treated with Fluoxetine chronically; the depressive symptoms improved by reversing the effect of methyl mercury on behaviour and BDNF gene expression.<xref ref-type="bibr" rid="B13"><sup>13</sup></xref></p>
<p>The acetylating agent L-acetylcarnitine (LAC), an antidepressant acts through epigenetic regulation of type 2 metabotropic glutamate (mGlu2) receptors. In studies it has caused rapid and long-lasting antidepressant effect in Flinders Sensitive Line rats and in mice exposed to chronic unpredictable stress, which, respectively, represent genetic and environmentally induced depression. LAC increased the levels of acetylated H3K27 bound to the Grm2 promoter and also increased acetylation of NF-&#x0138;B-p65 subunit, thereby intensifying the transcription of Grm2 gene encoding for the mGlu2 receptor in hippocampus and prefrontal cortex. LAC reduced the immobility time in the forced swim test and increased sucrose preference in 3 days of treatment, the antidepressant effect was seen 2 weeks after drug withdrawal.<xref ref-type="bibr" rid="B14"><sup>14</sup></xref></p>
</sec>
<sec>
<title>Epigenetic Mechanisms of Cocaine Addiction -</title>
<p>Positive experiences can also be epigenetically coded. Maladaptive compulsive drug seeking behaviour can occur when the natural rewarding system has been hijacked by highly rewarding exogenous substances. <xref ref-type="bibr" rid="B1"><sup>1</sup></xref></p>
<p>In rodents, the transition to addictive behaviour is mediated by epigenetic changes in the expression of genes that modify synaptic plasticity in neurons located in the reward system. Initial effects of cocaine cause transient expression of immediate early genes such as c-fos, whereas chronic use of cocaine increases the expression of late onset genes such as FosB/&#x0394;FosB, CDK5, BDNF.Histone acetylation plays a critical role in coordinating the transition from inducing immediate early genes to the stable expression of late onset genes. Manipulations that inhibit histone acetylation such as viral knockdown of HAT or the over-expression of different HDACs in the nucleus accumbens block the ability of chronic cocaine to induce late onset genes and reduce compulsive drug seeking behaviors.<xref ref-type="bibr" rid="B1"><sup>1</sup></xref></p>
</sec>
<sec>
<title>Epigenetic mechanisms in Memory -</title>
<p>In mammals, both DNA methylation and histone modifications play a role in learning and memory. DNA methyltransferase proteins DNMT3A and DNMT3B increase in expression in adult rat hippocampus in a particular learning and memory model. Conversely, treating these rats with a DNA methyltransferase inhibitor such as 5-azacytidine blocks memory formation and affects both the hippocampus and the cortex. Mice whose neurons over-express HDAC2 have poor long term memory. Increased acetylation levels in the brain seem to be consistently associated with improved memory.<xref ref-type="bibr" rid="B2"><sup>2</sup></xref></p>
</sec>
</sec>
<sec>
<title>Epigenetics in clinical setting</title>
<sec>
<title>Fragile X Syndrome</title>
<p>It is anX-linked monogenetic neuro-developmental psychiatric disorder, characterised by moderate intellectual disability, social deficits, a high incidence of attention deficit hyperactivity disorder (ADHD) and multiple physical abnormalities. It is caused by loss of function of the fragile X mental retardation gene 1 (FMR1). The FMR1 gene codes for an RNA binding protein that plays an important role in dendritic spine formation, explaining its impact on cognitive function and behaviour.DNA methylation is necessary to induce the clinical syndrome in individuals with full mutation. Hence Therapies preventing DNA methylation could potentially rescue the neurodevelopmental sequelae of individuals with fully mutated allele.<xref ref-type="bibr" rid="B1"><sup>1</sup></xref></p>
<p>Preliminary experiments using a lymphoblastoid cell line have been used to demethylate the fully mutated promoter and induce protein expression using a combination of DNMT and HDAC inhibitors.<xref ref-type="bibr" rid="B1"><sup>1</sup></xref></p>
</sec>
<sec>
<title>Post-traumatic stress disorder</title>
<p>Effects of stress on complex behaviours are mediated by genetic vulnerability. Childhood trauma preferentially interacts with a specific genetic predisposition to increase expression of the FK506-binding protein 5 (FKBP5) and vulnerability to PTSD and depression.<xref ref-type="bibr" rid="B1"><sup>1</sup></xref></p>
<p>FKBP5 is a stress related gene that exerts its effects via interaction with the GR. Under basal conditions, GR is maintained in the cytoplasm by the heat shock 90 and FKBP5 proteins, which bind GR and mask its nuclear localization signal. High levels of cortisol induced by stress dissociate Hsp90 and FKBP5 from GR, allowing it to enter the nucleus and induce 2 transcriptional programs. The first, is essential for terminating further release of cortisol from the adrenal gland, and second involves induction of FKBP5, a negative feedback loop that prevents further entry of GR into the nucleus. Retaining Gr in the cytoplasm is thought to reset the stress response so it can be reactivated in response to additional threats.<xref ref-type="bibr" rid="B1"><sup>1</sup></xref></p>
</sec>
<sec>
<title>Suicide Biomarker</title>
<p>Recent findings show that there are certain peripheral epigenetic markers that can predict suicide with more than 80&#x0025; accuracy hence these tragedies can be prevented. The DNA methylation patterns from the prefrontal cortex of depressed patients who committed suicide were studied as compared with depressed patients who died of other causes. DNA methylation is amenable to study in post mortem tissue because of its relative stability and its ability to predict gene expression. Only one gene coding for the spindle and kinetochore associated complex subunit 2 (SKA2) was identified to be differentially methylated in neurons of suicide committers.SKA2 is a scaffolding protein that chaperones the GR into the nucleus, thus terminating HPA activation in response to stress. It is a reliable retrospective biomarker of suicide.<xref ref-type="bibr" rid="B1"><sup>1</sup></xref></p>
<p>In addition, levels of SKA2 methylation in immune cells were highly correlated with morning cortisol levels suggesting a possible functional link between SKA2 methylation and stress levels. In some cases high levels of methylation at SKA2 were detected months before the onset of suicidal ideation, thus raising the possibility that this biomarker was present even before they developed suicidal thoughts.<xref ref-type="bibr" rid="B1"><sup>1</sup></xref></p>
<p>The inclusion of additional variables such as cortisol levels and anxiety further improved the predictive value of the model. This model was able to predict suicidal behavior with 71&#x0025; accuracy. Accuracy was increased to 82&#x0025; when levels of salivary cortisol were added. Predictive value further improved to 97&#x0025; on refining the stringency of categorizing suicidal ideations.<xref ref-type="bibr" rid="B1"><sup>1</sup></xref></p>
<p>In one study, patients who had suffered from childhood maltreatment, especially physical abuse, had high rates of DNA methylation of specific CpG sites in the glucocorticoid response element region of the 5-HT3AR, which may be associated with the frequency of suicide attempts and hospitalizations.<xref ref-type="bibr" rid="B1"><sup>1</sup></xref></p>
</sec>
<sec>
<title>Borderline Personality Disorder</title>
<p>The DSM-5 defines borderline personality disorder as &#x201C;a pattern of instability in interpersonal relationships, self-image, and affects, and marked impulsivity&#x201D;.<xref ref-type="bibr" rid="B6"><sup>6</sup></xref> There are multiple studies that indicate that childhood maltreatment, specifically sexual abuse, is both commonly reported in and strongly associated with borderline personality disorder, with symptoms of the personality disorder, such as derealization or dysphoria, predictive of childhood abuse.<sup>7&#x2013;9</sup>Individuals with a history of childhood physical abuse, sexual abuse or neglect were four times more likely to have a personality disorder in early adulthood compared with individuals who did not have such a history.<sup><xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B13">13</xref></sup></p>
<p>Glucocorticoid receptor gene NR3C1 is a target of early life stress because increased methylation of its promoter region in exon 1F has been documented in both, patients with childhood trauma and patients with borderline personality disorder.<sup><xref ref-type="bibr" rid="B14">14</xref>&#x2013;<xref ref-type="bibr" rid="B16">16</xref></sup></p>
</sec>
<sec>
<title>Atypical Antipsychotic Regulation</title>
<p>Histone deacetylases (HDACs) compact chromatin structure and represses gene transcription.<xref ref-type="bibr" rid="B17"><sup>17</sup></xref> In schizophrenia, preclinical <sup><xref ref-type="bibr" rid="B18">18</xref>&#x2013;<xref ref-type="bibr" rid="B20">20</xref></sup> and clinical <sup><xref ref-type="bibr" rid="B21">21</xref>&#x2013;<xref ref-type="bibr" rid="B23">23</xref></sup> studies suggest that drugs such as valproate, one of whose functions is to act as a nonspecific histone deacetylase (HDAC) inhibitor <sup><xref ref-type="bibr" rid="B24">24</xref>, <xref ref-type="bibr" rid="B25">25</xref></sup> are efficacious when given chronically in combination with atypical antipsychotic drugs. Chronic atypical antipsychotics down-regulates the transcription of metabotropic glutamate 2 receptor (mGlu2), an effect that is associated with decreased histone acetylation at its promoter in mouse and human frontal cortex,<xref ref-type="bibr" rid="B26"><sup>26</sup></xref> a brain region that is important in cognition and perception, and has been implicated more recently in schizophrenia and antipsychotic responses.<sup><xref ref-type="bibr" rid="B27">27</xref>, <xref ref-type="bibr" rid="B28">28</xref></sup></p>
<p>This epigenetic change occurred in concert with a serotonin 5-HT2A receptor-dependent up-regulation and increased binding of HDAC2 to the mGlu2 promoter.Virally mediated over-expression of HDAC2 in frontal cortex decreased mGlu2 transcription, thereby increasing psychosis like behaviour.<xref ref-type="bibr" rid="B17"><sup>17</sup></xref></p>
<p>HDAC inhibitors (sodium valproate) prevent the repressive histone modifications induced at the mGlu2 promoter by atypical antipsychotics and augment their therapeutic effects.<sup><xref ref-type="bibr" rid="B24">24</xref>, <xref ref-type="bibr" rid="B25">25</xref></sup></p>
</sec>
</sec>
<sec sec-type="conclusion">
<title>Conclusion</title>
<p>Epigenetics is such an exciting frontier in psychiatry, providing long sought biomarkers for predicting complex and devastating human behaviours as well as mental illnesses.</p>
</sec>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1.</label>
<mixed-citation>Jeniffer B Dwyer, Arie Kaffman. Epigenetics in Psychiatry: The promise for New Biomarkers and Treatments. In: Benjamin James Sadock, Virginia Alcott Sadock, Pedro Ruiz (Eds). Kaplan &#x0026; Sadock&#x2019;s Comprehensive Textbook of Psychiatry. Tenth Edition. Philadelphia: Wolter Kluwer; 2017.p 386-400.</mixed-citation>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Jeniffer</surname>
<given-names>B Dwyer</given-names>
</name>
<name>
<surname>Arie</surname>
<given-names>Kaffman</given-names>
</name>
</person-group>
<chapter-title>Epigenetics in Psychiatry: The promise for New Biomarkers and Treatments</chapter-title>
<comment>In</comment>
<person-group person-group-type="editor">
<name>
<surname>Benjamin</surname>
<given-names>James Sadock</given-names>
</name>
<name>
<surname>Virginia</surname>
<given-names>Alcott Sadock</given-names>
</name>
<name>
<surname>Pedro</surname>
<given-names>Ruiz</given-names>
</name>
</person-group>
<comment>Eds</comment>
<source>Kaplan &#x0026; Sadock&#x2019;s Comprehensive Textbook of Psychiatry</source>
<edition>Tenth</edition>
<comment>Edition</comment>
<publisher-loc>Philadelphia</publisher-loc>
<publisher-name>Wolter Kluwer</publisher-name>
<year>2017</year>
<comment>p</comment>
<fpage>386</fpage>
<lpage>400</lpage>
</element-citation>
</ref>
<ref id="B2">
<label>2.</label>
<mixed-citation>Carey N. The epigenetics revolution: How modern biology is rewriting our understanding of genetics, disease, and inheritance. Columbia University Press; 2012.</mixed-citation>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Carey</surname>
<given-names>N</given-names>
</name>
</person-group>
<source>The epigenetics revolution: How modern biology is rewriting our understanding of genetics, disease, and inheritance</source>
<publisher-name>Columbia University Press</publisher-name>
<year>2012</year>
</element-citation>
</ref>
<ref id="B3">
<label>3.</label>
<mixed-citation>Vale W, Spiess J, Rivier C, Rivier J. Characterization of a 41-Residue Ovine Hypothalamic Peptide that Stimulates Secretion of Corticotropin and &#x03B2;-endorphin. Science. 1981;213(4514):1394&#x2013;7.</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vale</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Spiess</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Rivier</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Rivier</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Characterization of a 41-Residue Ovine Hypothalamic Peptide that Stimulates Secretion of Corticotropin and &#x03B2;-endorphin</article-title>
<source>Science</source>
<year>1981</year>
<volume>213</volume>
<issue>4514</issue>
<fpage>1394</fpage>
<lpage>7</lpage>
</element-citation>
</ref>
<ref id="B4">
<label>4.</label>
<mixed-citation>Rivier C, Vale W. Modulation of stress-induced ACTH release by corticotropin-releasing factor, catecholamines and vasopressin. Nature. 198;305(5932):325&#x2013;7.</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rivier</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Vale</surname>
<given-names>W</given-names>
</name>
</person-group>
<article-title>Modulation of stress-induced ACTH release by corticotropin-releasing factor, catecholamines and vasopressin</article-title>
<source>Nature</source>
<year>198</year>
<volume>305</volume>
<issue>5932</issue>
<fpage>325</fpage>
<lpage>7</lpage>
</element-citation>
</ref>
<ref id="B5">
<label>5.</label>
<mixed-citation>Keller-Wood ME, Dallman MF. Corticosteroid inhibition of ACTH secretion. Endocr Rev. 1984;5(1):1&#x2013;24.</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Keller-Wood</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Dallman</surname>
<given-names>MF</given-names>
</name>
</person-group>
<article-title>Corticosteroid inhibition of ACTH secretion</article-title>
<source>Endocr Rev</source>
<year>1984</year>
<volume>5</volume>
<issue>1</issue>
<fpage>1</fpage>
<lpage>24</lpage>
</element-citation>
</ref>
<ref id="B6">
<label>6.</label>
<mixed-citation>Regier DA, Narrow WE, Clarke DE, Kraemer HC, Kuramoto SJ, Kuhl EA, et al. DSM-5 Field Trials in the United States and Canada, Part II: Test-Retest Reliability of Selected Categorical Diagnoses. Am JPsychiatry 2013;170(1):59&#x2013;70.</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Regier</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Narrow</surname>
<given-names>WE</given-names>
</name>
<name>
<surname>Clarke</surname>
<given-names>DE</given-names>
</name>
<name>
<surname>Kraemer</surname>
<given-names>HC</given-names>
</name>
<name>
<surname>Kuramoto</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Kuhl</surname>
<given-names>EA</given-names>
</name>
<etal>et al</etal>
</person-group>
<article-title>DSM-5 Field Trials in the United States and Canada, Part II: Test-Retest Reliability of Selected Categorical Diagnoses</article-title>
<source>Am JPsychiatry</source>
<year>2013</year>
<volume>170</volume>
<issue>1</issue>
<fpage>59</fpage>
<lpage>70</lpage>
</element-citation>
</ref>
<ref id="B7">
<label>7.</label>
<mixed-citation>Ogata SN, Silk KR, Goodrich S, Lohr NE, Westen D, Hill EM. Childhood sexual and physical abuse in adult patients with borderline personality disorder. Am J Psychiatry. 1990;147(8):1008-13.</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ogata</surname>
<given-names>SN</given-names>
</name>
<name>
<surname>Silk</surname>
<given-names>KR</given-names>
</name>
<name>
<surname>Goodrich</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Lohr</surname>
<given-names>NE</given-names>
</name>
<name>
<surname>Westen</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Hill</surname>
<given-names>EM</given-names>
</name>
</person-group>
<article-title>Childhood sexual and physical abuse in adult patients with borderline personality disorder</article-title>
<source>Am J Psychiatry</source>
<year>1990</year>
<volume>147</volume>
<issue>8</issue>
<fpage>1008</fpage>
<lpage>13</lpage>
</element-citation>
</ref>
<ref id="B8">
<label>8.</label>
<mixed-citation>Herman JL, Perry C, Van der Kolk BA. Childhood trauma in borderline personality disorder. Am J Psychiatry. 1989;146(4):490.</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Herman</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Perry</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Van der Kolk</surname>
<given-names>BA</given-names>
</name>
</person-group>
<article-title>Childhood trauma in borderline personality disorder</article-title>
<source>Am J Psychiatry</source>
<year>1989</year>
<volume>146</volume>
<issue>4</issue>
<fpage>490</fpage>
</element-citation>
</ref>
<ref id="B9">
<label>9.</label>
<mixed-citation>Zanarini MC, Gunderson JG, Marino MF, Schwartz EO, Frankenburg FR. Childhood experiences of borderline patients. Comprehensive Psychiatry. 1989;30(1):18&#x2013;25.</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zanarini</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Gunderson</surname>
<given-names>JG</given-names>
</name>
<name>
<surname>Marino</surname>
<given-names>MF</given-names>
</name>
<name>
<surname>Schwartz</surname>
<given-names>EO</given-names>
</name>
<name>
<surname>Frankenburg</surname>
<given-names>FR</given-names>
</name>
</person-group>
<article-title>Childhood experiences of borderline patients</article-title>
<source>Comprehensive Psychiatry</source>
<year>1989</year>
<volume>30</volume>
<issue>1</issue>
<fpage>18</fpage>
<lpage>25</lpage>
</element-citation>
</ref>
<ref id="B10">
<label>10.</label>
<mixed-citation>Charoensook J. Is Epigenetic Stress the Link Between Childhood Maltreatment and Borderline Personality Disorder? American Journal of Psychiatry Residents&#x2019; Journal. 2017;12(6):2&#x2013;4.</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Charoensook</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Is Epigenetic Stress the Link Between Childhood Maltreatment and Borderline Personality Disorder?</article-title> <source>American Journal of Psychiatry Residents&#x2019; Journal</source>
<year>2017</year>
<volume>12</volume>
<issue>6</issue>
<fpage>2</fpage>
<lpage>4</lpage>
</element-citation>
</ref>
<ref id="B11">
<label>11.</label>
<mixed-citation>Trerotola M, Relli V, Simeone P, Alberti S. Epigenetic inheritance and the missing heritability. Human genomics. 2015 Dec;9(1):17.</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Trerotola</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Relli</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Simeone</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Alberti</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Epigenetic inheritance and the missing heritability</article-title>
<source>Human genomics</source>
<year>2015</year>
<month>Dec</month>
<volume>9</volume>
<issue>1</issue>
<fpage>17</fpage>
</element-citation>
</ref>
<ref id="B12">
<label>12.</label>
<mixed-citation>Galton, F. (1883) &#x201C;History of Twins&#x201D; in Human Faculty and its Development, McMillan and Co.</mixed-citation>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Galton</surname>
<given-names>F</given-names>
</name>
</person-group>
<year>1883</year>
<source>&#x201C;History of Twins&#x201D; in Human Faculty and its Development</source>
<publisher-name>McMillan and Co</publisher-name>
</element-citation>
</ref>
<ref id="B13">
<label>13.</label>
<mixed-citation>Onishchenko N, Karpova N, Sabri F, Castr&#x00E9;n E, Ceccatelli S. Long-lasting depression-like behavior and epigenetic changes of BDNF gene expression induced by perinatal exposure to methylmercury. Journal of neurochemistry. 2008 Aug;106(3):1378-87.</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Onishchenko</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Karpova</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Sabri</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Castr&#x00E9;n</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Ceccatelli</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Long-lasting depression-like behavior and epigenetic changes of BDNF gene expression induced by perinatal exposure to methylmercury</article-title>
<source>Journal of neurochemistry</source>
<year>2008</year>
<month>Aug</month>
<volume>106</volume>
<issue>3</issue>
<fpage>1378</fpage>
<lpage>87</lpage>
</element-citation>
</ref>
<ref id="B14">
<label>14.</label>
<mixed-citation>Perroud N, Paoloni-Giacobino A, Prada P, Oli&#x00E9; E, Salzmann A, Nicastro R, et al. Increased methylation of glucocorticoid receptor gene (<italic>NR3C1</italic>) in adults with a history of childhood maltreatment: a link with the severity and type of trauma. Translational Psychiatry. 2011;1(12):e59.</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Perroud</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Paoloni-Giacobino</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Prada</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Oli&#x00E9;</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Salzmann</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Nicastro</surname>
<given-names>R</given-names>
</name>
<etal>et al</etal>
</person-group>
<article-title>Increased methylation of glucocorticoid receptor gene (<italic>NR3C1</italic>) in adults with a history of childhood maltreatment: a link with the severity and type of trauma</article-title>
<source>Translational Psychiatry</source>
<year>2011</year>
<volume>1</volume>
<issue>12</issue>
<fpage>e59</fpage>
</element-citation>
</ref>
<ref id="B15">
<label>15.</label>
<mixed-citation>Mart&#x00ED;n-Blanco A, Ferrer M, Soler J, Salazar J, Vega D, Andi&#x00F3;n O, et al. Association between methylation of the glucocorticoid receptor gene, childhood maltreatment, and clinical severity in borderline personality disorder. Journal of Psychiatric Research. 2014;57:34&#x2013;40.</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mart&#x00ED;n-Blanco</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ferrer</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Soler</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Salazar</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Vega</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Andi&#x00F3;n</surname>
<given-names>O</given-names>
</name>
<etal>et al</etal>
</person-group>
<article-title>Association between methylation of the glucocorticoid receptor gene, childhood maltreatment, and clinical severity in borderline personality disorder</article-title>
<source>Journal of Psychiatric Research</source>
<year>2014</year>
<volume>57</volume>
<fpage>34</fpage>
<lpage>40</lpage>
</element-citation>
</ref>
<ref id="B16">
<label>16.</label>
<mixed-citation>Radtke KM, Schauer M, Gunter HM, Ruf-Leuschner M, Sill J, Meyer A, et al. Epigenetic modifications of the glucocorticoid receptor gene are associated with the vulnerability to psychopathology in childhood maltreatment. Translational Psychiatry. 2015;5(5):e571.</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Radtke</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Schauer</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gunter</surname>
<given-names>HM</given-names>
</name>
<name>
<surname>Ruf-Leuschner</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sill</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Meyer</surname>
<given-names>A</given-names>
</name>
<etal>et al</etal>
</person-group>
<article-title>Epigenetic modifications of the glucocorticoid receptor gene are associated with the vulnerability to psychopathology in childhood maltreatment</article-title>
<source>Translational Psychiatry</source>
<year>2015</year>
<volume>5</volume>
<issue>5</issue>
<fpage>e571</fpage>
</element-citation>
</ref>
<ref id="B17">
<label>17.</label>
<mixed-citation>Kurita M, Holloway T, Garc&#x00ED;a-Bea A, Kozlenkov A, Friedman AK, Moreno JL, et al. HDAC2 regulates atypical antipsychotic responses through the modulation of <italic>mGlu2</italic> promoter activity. Nature Neuroscience. 2012;15(9):1245&#x2013;54.</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kurita</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Holloway</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Garc&#x00ED;a-Bea</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kozlenkov</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Friedman</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Moreno</surname>
<given-names>JL</given-names>
</name>
<etal>et al</etal>
</person-group>
<article-title>HDAC2 regulates atypical antipsychotic responses through the modulation of <italic>mGlu2</italic> promoter activity</article-title>
<source>Nature Neuroscience</source>
<year>2012</year>
<volume>15</volume>
<issue>9</issue>
<fpage>1245</fpage>
<lpage>54</lpage>
</element-citation>
</ref>
<ref id="B18">
<label>18.</label>
<mixed-citation>Dong E, Guidotti A, Grayson DR, Costa E. Histone hyperacetylation induces demethylation of reelin and 67-kDa glutamic acid decarboxylase promoters. PNAS. 2007;104(11):4676&#x2013;81.</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dong</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Guidotti</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Grayson</surname>
<given-names>DR</given-names>
</name>
<name>
<surname>Costa</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Histone hyperacetylation induces demethylation of reelin and 67-kDa glutamic acid decarboxylase promoters</article-title>
<source>PNAS</source>
<year>2007</year>
<volume>104</volume>
<issue>11</issue>
<fpage>4676</fpage>
<lpage>81</lpage>
</element-citation>
</ref>
<ref id="B19">
<label>19.</label>
<mixed-citation>Dong E, Nelson M, Grayson DR, Costa E, Guidotti A. Clozapine and sulpiride but not haloperidol or olanzapine activate brain DNA demethylation. PNAS. 2008;105(36):13614&#x2013;9.</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dong</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Nelson</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Grayson</surname>
<given-names>DR</given-names>
</name>
<name>
<surname>Costa</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Guidotti</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Clozapine and sulpiride but not haloperidol or olanzapine activate brain DNA demethylation</article-title>
<source>PNAS</source>
<year>2008</year>
<volume>105</volume>
<issue>36</issue>
<fpage>13614</fpage>
<lpage>9</lpage>
</element-citation>
</ref>
<ref id="B20">
<label>20.</label>
<mixed-citation>Abel T, Zukin RS. Epigenetic targets of HDAC inhibition in neurodegenerative and psychiatric disorders. Curr Opin Pharmacol. 2008;8(1):57&#x2013;64.</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abel</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Zukin</surname>
<given-names>RS</given-names>
</name>
</person-group>
<article-title>Epigenetic targets of HDAC inhibition in neurodegenerative and psychiatric disorders</article-title>
<source>Curr Opin Pharmacol</source>
<year>2008</year>
<volume>8</volume>
<issue>1</issue>
<fpage>57</fpage>
<lpage>64</lpage>
</element-citation>
</ref>
<ref id="B21">
<label>21.</label>
<mixed-citation>Citrome L, Casey DE, Daniel DG, Wozniak P, Kochan LD, Tracy KA. Adjunctive Divalproex and Hostility Among Patients With Schizophrenia Receiving Olanzapine or Risperidone. Psychiatr Serv. 2004;55(3):290&#x2013;4.</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Citrome</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Casey</surname>
<given-names>DE</given-names>
</name>
<name>
<surname>Daniel</surname>
<given-names>DG</given-names>
</name>
<name>
<surname>Wozniak</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Kochan</surname>
<given-names>LD</given-names>
</name>
<name>
<surname>Tracy</surname>
<given-names>KA</given-names>
</name>
</person-group>
<article-title>Adjunctive Divalproex and Hostility Among Patients With Schizophrenia Receiving Olanzapine or Risperidone</article-title>
<source>Psychiatr Serv</source>
<year>2004</year>
<volume>55</volume>
<issue>3</issue>
<fpage>290</fpage>
<lpage>4</lpage>
</element-citation>
</ref>
<ref id="B22">
<label>22.</label>
<mixed-citation>Kelly DL, Conley RR, Feldman S, Yu Y, McMahon RP, Richardson CM. Adjunct Divalproex or Lithium to Clozapine in Treatment-Resistant Schizophrenia. Psychiatr Q. 2006;77(1):81&#x2013;95.</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kelly</surname>
<given-names>DL</given-names>
</name>
<name>
<surname>Conley</surname>
<given-names>RR</given-names>
</name>
<name>
<surname>Feldman</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>McMahon</surname>
<given-names>RP</given-names>
</name>
<name>
<surname>Richardson</surname>
<given-names>CM</given-names>
</name>
</person-group>
<article-title>Adjunct Divalproex or Lithium to Clozapine in Treatment-Resistant Schizophrenia</article-title>
<source>Psychiatr Q</source>
<year>2006</year>
<volume>77</volume>
<issue>1</issue>
<fpage>81</fpage>
<lpage>95</lpage>
</element-citation>
</ref>
<ref id="B23">
<label>23.</label>
<mixed-citation>Suzuki T, Uchida H, Takeuchi H, Nakajima S, Nomura K, Tanabe A, et al. Augmentation of atypical antipsychotics with valproic acid. An open-label study for most difficult patients with schizophrenia. Human Psychopharmacology: Clinical and Experimental. 2009;24(8):628&#x2013;38.</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Suzuki</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Uchida</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Takeuchi</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Nakajima</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Nomura</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Tanabe</surname>
<given-names>A</given-names>
</name>
<etal>et al</etal>
</person-group>
<article-title>Augmentation of atypical antipsychotics with valproic acid. An open-label study for most difficult patients with schizophrenia</article-title>
<source>Human Psychopharmacology: Clinical and Experimental</source>
<year>2009</year>
<volume>24</volume>
<issue>8</issue>
<fpage>628</fpage>
<lpage>38</lpage>
</element-citation>
</ref>
<ref id="B24">
<label>24.</label>
<mixed-citation>L&#x00F6;scher W. Valproate: a reappraisal of its pharmacodynamic properties and mechanisms of action. Progress in Neurobiology. 1999;58(1):31&#x2013;59.</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>L&#x00F6;scher</surname>
<given-names>W</given-names>
</name>
</person-group>
<article-title>Valproate: a reappraisal of its pharmacodynamic properties and mechanisms of action</article-title>
<source>Progress in Neurobiology</source>
<year>1999</year>
<volume>58</volume>
<issue>1</issue>
<fpage>31</fpage>
<lpage>59</lpage>
</element-citation>
</ref>
<ref id="B25">
<label>25.</label>
<mixed-citation>Gurvich N, Tsygankova OM, Meinkoth JL, Klein PS. Histone Deacetylase Is a Target of Valproic Acid-Mediated Cellular Differentiation. Cancer Res. 2004;64(3):1079&#x2013;86.</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gurvich</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Tsygankova</surname>
<given-names>OM</given-names>
</name>
<name>
<surname>Meinkoth</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Klein</surname>
<given-names>PS</given-names>
</name>
</person-group>
<article-title>Histone Deacetylase Is a Target of Valproic Acid-Mediated Cellular Differentiation</article-title>
<source>Cancer Res</source>
<year>2004</year>
<volume>64</volume>
<issue>3</issue>
<fpage>1079</fpage>
<lpage>86</lpage>
</element-citation>
</ref>
<ref id="B26">
<label>26.</label>
<mixed-citation>Gonz&#x00E1;lez-Maeso J, Ang RL, Yuen T, Chan P, Weisstaub NV, L&#x00F3;pez-Gim&#x00E9;nez JF, et al. Identification of a serotonin/glutamate receptor complex implicated in psychosis. Nature. 2008;452(7183):93&#x2013;7.</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gonz&#x00E1;lez-Maeso</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Ang</surname>
<given-names>RL</given-names>
</name>
<name>
<surname>Yuen</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Chan</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Weisstaub</surname>
<given-names>NV</given-names>
</name>
<name>
<surname>L&#x00F3;pez-Gim&#x00E9;nez</surname>
<given-names>JF</given-names>
</name>
<etal>et al</etal>
</person-group>
<article-title>Identification of a serotonin/glutamate receptor complex implicated in psychosis</article-title>
<source>Nature</source>
<year>2008</year>
<volume>452</volume>
<issue>7183</issue>
<fpage>93</fpage>
<lpage>7</lpage>
</element-citation>
</ref>
<ref id="B27">
<label>27.</label>
<mixed-citation>Gonz&#x00E1;lez-Maeso J, Sealfon SC. Psychedelics and schizophrenia. Trends in Neurosciences. 2009; 32(4):225&#x2013;32.</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gonz&#x00E1;lez-Maeso</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Sealfon</surname>
<given-names>SC</given-names>
</name>
</person-group>
<article-title>Psychedelics and schizophrenia</article-title>
<source>Trends in Neurosciences</source>
<year>2009</year>
<volume>32</volume>
<issue>4</issue>
<fpage>225</fpage>
<lpage>32</lpage>
</element-citation>
</ref>
<ref id="B28">
<label>28.</label>
<mixed-citation>Gonz&#x00E1;lez-Maeso J, Weisstaub NV, Zhou M, Chan P, Ivic L, Ang R, et al. Hallucinogens Recruit Specific Cortical 5-HT2A Receptor-Mediated Signaling Pathways to Affect Behavior. Neuron. 2007;53(3):439&#x2013;52.</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gonz&#x00E1;lez-Maeso</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Weisstaub</surname>
<given-names>NV</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Chan</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Ivic</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Ang</surname>
<given-names>R</given-names>
</name>
<etal>et al</etal>
</person-group>
<article-title>Hallucinogens Recruit Specific Cortical 5-HT2A Receptor-Mediated Signaling Pathways to Affect Behavior</article-title>
<source>Neuron</source>
<year>2007</year>
<volume>53</volume>
<issue>3</issue>
<fpage>439</fpage>
<lpage>52</lpage>
</element-citation>
</ref>
</ref-list>
</back>
</article>